MedPath

Supraventricular Tachycardia Collection Study

Completed
Conditions
Supraventricular Arrhythmias
Registration Number
NCT02158728
Lead Sponsor
Medtronic Cardiac Rhythm and Heart Failure
Brief Summary

To collect supraventricular tachycardia (SVT) data for developing and testing sensing and detection algorithms for a subcutaneous implantable cardioverter defibrillator (ICD).

Detailed Description

The purpose of the SVT Collect study is to collect supraventricular tachycardia episode data for developing and testing new sensing and detection algorithms for a future subcutaneous ICD.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Subjects aged 18 or above, or of legal age to give consent specific to the national law of the countries in which the trial is being conducted
  • Subjects indicated for implantable cardioverter defibrillator (ICD)/cardiac resynchronization therapy defibrillator (CRT-D) implant or ICD/CRT-D change-out, OR subjects indicated for an ICD/CRT-D that are undergoing ablation or electrophysiology (EP) study (including Non-invasive EP Study [NIPS])
  • Subjects are willing to provide Informed Consent
Exclusion Criteria
  • Subjects who are ventricular pacing dependent
  • Subjects with a preexisting dual/triple chamber pacemaker or ICD who have a history of atrioventricular (AV) block with atrial pacing < 120 beats per minute (BPM) while awake.
  • Subjects who are unable to tolerate elevated ventricular rates (≥170BPM)
  • Any condition which precludes the subject's ability to comply with the study requirements
  • Enrollment in a concurrent study (without prior study management approval) that may confound the results of this study
  • Subjects who are legally incompetent
  • Subjects meet exclusion criteria required by local laws and regulations (e.g. age, breast feeding, etc).

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Number of Electrocardiograms (ECGs) CollectedAfter recorded ECGs had been received, which were collected until the end of the indicated procedure

Collected were the number of ECGs received from the enrolled subjects, the number of ECGs with SVT (supraventricular tachycardia) episodes, and the number of ECGs with SVT episodes qualified for algorithm development and validation of the potential new ICD. The ECG data were collected continuously during the indicated procedure (ICD/CRT-D implant, ICD/CRT-D change-out, electrophysiology (EP) study (including non invasive EP study)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Semmelweis University

🇭🇺

Budapest, Hungary

© Copyright 2025. All Rights Reserved by MedPath